The safety, efficacy, and influencing factors of biodegradable versus metallic occluders in the treatment of migraine patients with patent foramen ovale. [PDF]
Sun K +8 more
europepmc +1 more source
Pulmonary embolism with patent Foramen Ovale: a distinct clinical entity demanding tailored management and screening. [PDF]
Ajam M, Ran R.
europepmc +1 more source
Reduced pulmonary vascular bed volume in cryptogenic stroke patients with patent foramen ovale: a myocardial contrast echocardiography study. [PDF]
Xu L, Zhang J, Wang D, Lv Y, Zheng X.
europepmc +1 more source
Patent Foramen Ovale Closure in a Patient With Ventricular Storm and Arrhythmogenic Right Ventricular Cardiomyopathy. [PDF]
Chiu MH, Keshvara RA.
europepmc +1 more source
When Does a Patent Foramen Ovale Become a Lifesaver or a Liability in Acute Pulmonary Embolism? [PDF]
Sabesan V +4 more
europepmc +1 more source
Serotonin as a potential marker of endothelial dysfunction for cerebral embolism in patients with persistent foramen ovale. [PDF]
Tworek M +9 more
europepmc +1 more source
Percutaneous closure of patent foramen ovale with complex anatomy using the Memopart™ occluder device. [PDF]
Gili S +6 more
europepmc +1 more source
Preliminary study on the application of percutaneous patent foramen ovale (PFO) closure in the treatment of children with PFO and severe migraine. [PDF]
Ji L +6 more
europepmc +1 more source

